Quidel Corporation and Ortho Clinical Diagnostics Combine to Form QuidelOrtho

EKF Diagnostics Acquires ADL Health (Advanced Diagnostic Laboratory LLC)

November 11, 2021

Healthcare Services

EKF Diagnostics has acquired Advanced Diagnostic Laboratory LLC (ADL Health), a Texas-based CLIA-certified molecular diagnostics laboratory focused on PCR and high-throughput COVID-19 testing. The acquisition expands EKF's diagnostics capability by adding clinical laboratory testing services and ISO 15189-accredited operations to support a broader ‘sample-to-result’ offering and anticipated investment in equipment and personnel.

Q² Solutions (IQVIA) Acquires Nexelis from Ampersand Capital Partners

January 10, 2022

Healthcare Services

Ampersand Capital Partners sold its portfolio company Nexelis to Q² Solutions, a wholly owned subsidiary of IQVIA, Inc. Nexelis, a Laval, Quebec–based provider of assay development and advanced clinical-trial laboratory testing with five operating sites in North America and Europe, will be integrated into IQVIA's global laboratory services to expand capabilities and capacity for vaccine, immunology and other drug-development testing.

Gilead Sciences Acquires Immunomedics

September 13, 2020

Biotechnology

Gilead Sciences agreed to acquire Immunomedics for $88.00 per share in an all-cash transaction valuing Immunomedics at approximately $21 billion. The acquisition gives Gilead global rights (outside certain Asian territories) to Trodelvy, an FDA‑approved antibody‑drug conjugate for metastatic triple‑negative breast cancer, and accelerates Gilead’s expansion into oncology.

Discovery Life Sciences Acquires QualTek Molecular Laboratories

May 5, 2019

Healthcare Services

Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.

LabGenomics USA LLC Acquires QDx Pathology

September 5, 2023

Healthcare Services

LabGenomics USA LLC, a subsidiary of South Korea–based LabGenomics Co., Ltd., has acquired QDx Pathology, a U.S. clinical and molecular pathology laboratory. The deal, signed in August 2023, is intended to accelerate LabGenomics' entry and expansion into the North American diagnostics market by combining QDx's lab services with LabGenomics' NGS-based molecular diagnostics capabilities.

Catabasis Pharmaceuticals Acquires Quellis Biosciences Inc.

January 29, 2021

Biotechnology

Catabasis Pharmaceuticals has acquired Quellis Biosciences in a stock-for-stock merger to obtain Quellis' lead preclinical monoclonal antibody program QLS-215 for hereditary angioedema. Concurrent with the acquisition, Catabasis completed a private placement (PIPE) led by Perceptive Advisors and other institutional investors to raise approximately $110 million to fund IND-enabling studies and early clinical trials of QLS-215.